Human LXN (TCI) knockout HeLa cell line (ab265921)
Properties
-
Number of cells
1 x 106 cells/vial, 1 mL -
Viability
~90% -
Adherent /Suspension
Adherent -
Tissue
Cervix -
Cell type
epithelial -
Disease
Adenocarcinoma -
Gender
Female -
STR Analysis
Amelogenin X D5S818: 11, 12 D13S317: 12, 13.3 D7S820: 8, 12 D16S539: 9, 10 vWA: 16, 18 TH01: 7 TPOX: 8, 12 CSF1PO: 9, 10 -
Mycoplasma free
Yes -
Storage instructions
Shipped on Dry Ice. Store in liquid nitrogen. -
Storage buffer
Constituents: 8.7% Dimethylsulfoxide, 2% Cellulose, methyl ether -
Purity
Immunogen affinity purified -
Research areas
Images
-
Sanger Sequencing - Human LXN knockout HeLa cell line (ab265921)
Allele-1: 8 bp deletion in exon 1.
-
Sanger Sequencing - Human LXN knockout HeLa cell line (ab265921)Allele-2: 7 bp deletion in exon 1.
-
Sanger Sequencing - Human LXN knockout HeLa cell line (ab265921)Allele-3: Insertion of the selection cassette in exon 1.
